Comparison of Adiponectin Levels in Anorexia Nervosa, Bulimia Nervosa, Binge-Eating Disorder, Obesity, Constitutional Thinness, and Healthy Controls: A Network Meta-Analysis
Author:
Tural Umit1ORCID, Sparpana Allison12, Sullivan Elizabeth12, Iosifescu Dan V.12
Affiliation:
1. Clinical Research Division, The Nathan S. Kline Institute for Psychiatric Research, Orangeburg, NY 10962, USA 2. Psychiatry Department, New York University School of Medicine, New York, NY 10016, USA
Abstract
Adiponectin is a protein hormone that is produced and secreted primarily by adipose tissue. The levels of adiponectin in those with eating disorders, obesity, and healthy controls have been extensively studied. However, the general picture of the differences in adiponectin levels across the mentioned conditions is still unclear and fragmented. In this study, we pooled previous studies and performed a network meta-analysis to gain a global picture of comparisons of adiponectin levels across eating disorders, obesity, constitutional thinness, and healthy controls. Electronic databases were searched for anorexia nervosa, avoidant restrictive food intake disorder, binge-eating disorder, bulimia nervosa, healthy controls, night eating syndrome, obesity, and constitutional thinness in studies where adiponectin levels were measured. A total of 4262 participants from 50 published studies were included in the network meta-analysis. Adiponectin levels were significantly higher in participants with anorexia nervosa than in healthy controls (Hedges’ g = 0.701, p < 0.001). However, adiponectin levels in constitutionally thin participants were not significantly different from those of healthy controls (Hedges’ g = 0.470, p = 0.187). Obesity and binge-eating disorder were associated with significantly lower adiponectin levels compared to those of healthy controls (Hedges’ g = −0.852, p < 0.001 and Hedges’ g = −0.756, p = 0.024, respectively). The disorders characterized by excessive increases or decreases in BMI were associated with significant changes in adiponectin levels. These results suggest that adiponectin may be an important marker of severely disequilibrated homeostasis, especially in fat, glucose, and bone metabolisms. Nonetheless, an increase in adiponectin may not simply be associated with a decrease in BMI, as constitutional thinness is not associated with a significant increase in adiponectin.
Subject
Paleontology,Space and Planetary Science,General Biochemistry, Genetics and Molecular Biology,Ecology, Evolution, Behavior and Systematics
Reference82 articles.
1. Deloitte Access Economics (2020). The Social and Economic Cost of Eating Disorders in the United States of America: A Report for the Strategic Training Initiative for the Prevention of Eating Disorders and the Academy for Eating Disorders, Deloitte Access Economics. 2. Stierman, B., Joseph, A., Margaret, C., Chen, T.-C., Davy, O., Steven, F., and Cheryl, F. (2021). NHSR 158. National Health and Nutrition Examination Survey 2017–March 2020 Pre-Pandemic Data Files-Development of Files and Prevalence Estimates for Selected Health Outcomes, National Health Statistics Report. 3. Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity;Arita;Biochem. Biophys. Res. Commun.,1999 4. Effects of Exercise on Adiponectin: A Systematic Review;Simpson;Obesity,2008 5. Adiponectin Reduces Atherosclerosis in Apolipoprotein E-Deficient Mice;Okamoto;Circulation,2002
|
|